Edgewise Therapeutics Inc (EWTX)
EBITDA Growth
-59.59%
Quarterly · Period ending:
EWTX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-59.59%period ending
Latest reported-59.59%period ending
EWTX Quarterly EBITDA YoY % (-111.28% → -59.59%)
Year-over-year change
High-resolution chart · PNG
EWTX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -59.587% | |
| -20.3235% | |
| -27.177% | |
| -19.5932% | |
| -14.808% | |
| -43.7286% | |
| -31.8237% | |
| -32.9592% | |
| -47.2185% | |
| -23.9103% | |
| -53.2371% | |
| -45.4797% | |
| -32.1687% | |
| -55.4875% | |
| -53.1384% | |
| -34.5208% | |
| -54.4652% | |
| -114.4143% | |
| -100.4766% | |
| -258.614% | |
| -163.3436% | |
| -111.2843% |